Deficiency of GFRα1 promotes hepatocellular carcinoma progression but enhances oxaliplatin-mediated anti-tumor efficacy.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Pharmacological Research

• Publication date

  2021-08-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.phrs.2021.105815PMID 34391932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in immunotherapy for hepatocellular carcinoma

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Cancer Statistics, 2021

  2021cited by this paper
• Impact of GFRA1 gene reactivation by DNA demethylation on prognosis of patients with metastatic colon cancer.

  2020cited by this paper
• Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.

  2020cited by this paper
• Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

  2020cited by this paper
• circGFRA1 Promotes Ovarian Cancer Progression By Sponging miR-449a

  2019cited by this paper
• Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.

  2019cited by this paper
• A panel of DNA methylated markers predicts metastasis of pN0M0 gastric carcinoma: a prospective cohort study

  2019cited by this paper
• Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies

  2019cited by this paper
• Molecular therapies and precision medicine for hepatocellular carcinoma

  2018cited by this paper
• Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.

  2018cited by this paper
• GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance

  2018cited by this paper
• Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.

  2018cited by this paper
• An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast Cancer

  2017cited by this paper
• GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy

  2017cited by this paper
• Role of EMT in Metastasis and Therapy Resistance

  2016cited by this paper
• Tight junctions: from simple barriers to multifunctional molecular gates

  2016cited by this paper
• Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.

  2014cited by this paper
• GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling

  2014cited by this paper
• DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance

  2014cited by this paper
• Chemopreventive strategies in hepatocellular carcinoma

  2014cited by this paper
• Glial cell line-derived neurotrophic factor induces cell migration in human oral squamous cell carcinoma.

  2013cited by this paper
• Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, proteins binding ARTEMIN, in mammary carcinoma

  2013cited by this paper
• Tight junction proteins: from barrier to tumorigenesis.

  2013cited by this paper
• Neurotrophins and their receptors in breast cancer.

  2012cited by this paper
• Artemin Stimulates Radio- and Chemo-resistance by Promoting TWIST1-BCL-2-dependent Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells*

  2012cited by this paper
• Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells.

  2012cited by this paper
• The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity.

  2012cited by this paper
• Role of glial cell line-derived neurotrophic factor in perineural invasion of pancreatic cancer.

  2012cited by this paper
• Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells.

  2010cited by this paper
• Epithelial-mesenchymal transitions and hepatocarcinogenesis.

  2010cited by this paper
• Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

  2010cited by this paper
• Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells.

  2010cited by this paper
• Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves.

  2010cited by this paper
• E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer

  2009cited by this paper
• GDNF-induced cell signaling and neurite outgrowths are differentially mediated by GFRalpha1 isoforms.

  2009cited by this paper
• Ape1/Ref-1 Induces Glial Cell-Derived Neurotropic Factor (GDNF) Responsiveness by Upregulating GDNF Receptor α1 Expression

  2009cited by this paper
• Artemin is oncogenic for human mammary carcinoma cells

  2009cited by this paper
• GDNF and GFRalpha: a versatile molecular complex for developing neurons.

  2008cited by this paper
• Neurotrophins and their receptors stimulate melanoma cell proliferation and migration.

  2008cited by this paper
• GDNF and GFRα1 promote formation of neuronal synapses by ligand-induced cell adhesion

  2007cited by this paper
• A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer.

  2007cited by this paper
• Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts

  2006cited by this paper
• Large‐scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C

  2005cited by this paper
• Activation of Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase Is Required for Glial Cell Line-Derived Neurotrophic Factor-Induced Migration and Invasion of Pancreatic Carcinoma Cells

  2004cited by this paper
• Novel functions and signalling pathways for GDNF

  2003cited by this paper
• The GDNF family: Signalling, biological functions and therapeutic value

  2002cited by this paper
• Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-α1) are strongly expressed in human gliomas

  2000cited by this paper

• Neurotrophic signaling in liver cancers: mechanisms and potential therapeutic targets

  2025cites this paper
• Claudins and hepatocellular carcinoma.

  2024cites this paper
• Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers

  2024cites this paper
• Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer.

  2022cites this paper